EPCM
BIIB icon

Eton Park Capital Management’s Biogen BIIB Stock Holding History

Eton Park Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-111,191
Closed -$30.4M – 2
2017
Q1 		$30.4M Sell
111,191
-216,691
-66% -$61.3M 1.33% 20
2016
Q4 		$93M Buy
327,882
+263,882
+412% +$78.2M 1.85% 19
2016
Q3 		$20M Buy
+64,000
New +$19M 0.35% 43

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Eton Park Capital Management's BIIB Position: Q2 2017 in Review

Eton Park Capital Management sold out of Biogen (BIIB) in Q2 2017, closing a stake of 111,191 shares — an estimated $30.4M sold.

Eton Park Capital Management first reported a position in BIIB in Q3 2016 and held it in 3 quarters. The position peaked at $93M in Q4 2016. 992 funds tracked by Wall St. Rank hold BIIB as of Q2 2017.

  • Eton Park Capital Management reported no remaining Biogen position as of Q2 2017 after selling out during the quarter.
  • Eton Park Capital Management sold 111,191 Biogen shares in Q2 2017, an estimated $30.4M.
  • Eton Park Capital Management first reported a position in Biogen in Q3 2016 and held it in 3 quarters.
  • Eton Park Capital Management's Biogen position peaked at $93M in Q4 2016.
  • 992 funds tracked by Wall St. Rank held Biogen as of Q2 2017.

Based on Eton Park Capital Management's 13F filing for Q2 2017.